SCHEMBL6850489

SCHEMBL6850489

O=C([O-])c1cc(C(=O)[O-])cc(S(=O)(=O)O)c1.[Ba+2]

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LCK P06239 1/20 0.61
FYN P06241 1/20 0.61
TIMP3 P35625 2/20 0.40
LMNA P02545 1/20 0.39
ING2 Q9H160 1/20 0.39
CA2 P00918 6/20 0.38
CA1 P00915 5/20 0.38
ALDH1A1 P00352 4/20 0.38
TSHR P16473 2/20 0.38
NT5E P21589 2/20 0.38
HSD17B10 Q99714 3/20 0.37
KDM4E B2RXH2 1/20 0.37
HPGD P15428 1/20 0.37
CASP6 P55212 2/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
CYP1A2 P05177 1/20 0.35
NSD2 O96028 1/20 0.35
GAA P10253 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Potassium Ion SCHEMBL472665 0.95 LCK (0.61) LCKFYNTIMP3LMNAING2
SCHEMBL6292956 0.95 LCK (0.61) LCKFYNTIMP3LMNAING2
Zinc Ion SCHEMBL15387742 0.95 LCK (0.61) LCKFYNTIMP3LMNAING2
SCHEMBL258409 0.95 LCK (0.61) LCKFYNTIMP3LMNAING2
Lithium Ion SCHEMBL433795 0.95 LCK (0.61) LCKFYNTIMP3LMNAING2
SCHEMBL18192037 0.95 LCK (0.61) LCKFYNTIMP3LMNAING2
Potassium Ion SCHEMBL28394777 0.93 LCK (0.59) LCKFYNTIMP3LMNAING2
Lithium Ion SCHEMBL28391984 0.93 LCK (0.59) LCKFYNTIMP3LMNAING2
SCHEMBL7714609 0.91 LCK (0.56) LCKFYNTIMP3LMNAING2
Butane SCHEMBL6855826 0.90 LCK (0.52) LCKFYNTIMP3LMNAING2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6830859-B2 Electrostatic latent images; containing barium salt of sulfoisophthalic acid RICOH COMPANY, LTD. (JP) 2004-12-14 US disclosed
US-20030077534-A1 Charge control agent and toner using same RICOH COMPANY, LTD. (JP) 2003-04-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030077534-A1 Charge control agent and toner using same BET1, SMARCA5, SMARCA1 LCK 3088/4885FYN 3103/4885TIMP3 3021/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.